SHIVANNA SUBRAMANI GONZALEZ: Open Payments
NPI 1457758179 · WOLCOTT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 55 payments from 9 companies in 2025. Trend: 2023 $469 · 2024 $398 · 2025 $1,020
Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $572 |
| MILLICENT US INC | 6 | $105 |
| Astellas Pharma US Inc | 5 | $99 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $88 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Novo Nordisk Inc | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Organon LLC | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
Products named: VRAYLAR, Veozah, FEMLYV, Auvelity, QULIPTA, Ozempic, UBRELVY, FANAPT.
Industry payments across CT — which companies pay providers there.
